While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW ...

The global market for prostate cancer market is likely to be valued at around USD 12.9 billion in 2025 and is projected to ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

So as way of background, EZH2 is an epigenetic enzyme that's overexpressed in castrate-resistant prostate cancer, and it's ...

Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with ...

Patients with intermediate-risk prostate cancer had a 15-year prostate cancer–specific survival rate of 91% with EBRT ... releasing hormone analogues and ARPIs among patients with metastatic prostate ...

Recently, licensed and emerging treatments for metastatic ... a view to maximize survival as well. This article provides an overview of developments in advanced prostate cancer and considers ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...